{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:41:27Z","timestamp":1792024887872,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":508,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cmi.2022.06.023","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T02:22:36Z","timestamp":1657160556000},"page":"1650.e1-1650.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest"],"prefix":"10.1016","volume":"28","author":[{"given":"Trusha","family":"Nana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Perovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindana","family":"Chibabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.06.023_bib1","series-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.cmi.2022.06.023_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/antibiotics8030122","article-title":"Present and future of carbapenem-resistant enterobacteriaceae (CRE) infections","volume":"8","author":"Suay-Garc\u00eda","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2022.06.023_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.cmi.2022.06.023_bib4","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-producing organisms: a global scourge","volume":"66","author":"Bonomo","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.06.023_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10096-020-03845-4","article-title":"Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018","volume":"39","author":"Perovic","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2022.06.023_bib6","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1111\/1469-0691.12091","article-title":"Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge","volume":"19","author":"Navarro-San Francisco","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.06.023_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024880","article-title":"Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia","volume":"100","author":"Rodr\u00edguez","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cmi.2022.06.023_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12879-019-4409-1","article-title":"Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae","volume":"19","author":"Alraddadi","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2022.06.023_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diagmicrobio.2015.05.018","article-title":"An 11,000-isolate same plate\/same day comparison of the 3 most widely used platforms for analyzing multidrug-resistant clinical pathogens","volume":"83","author":"Nielsen","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2022.06.023_bib10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2147\/IDR.S166790","article-title":"Comparison of five commonly used automated susceptibility testing methods for accuracy in the China Antimicrobial Resistance Surveillance System (CARSS) hospitals","volume":"11","author":"Zhou","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2022.06.023_bib11","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/JCM.00267-10","article-title":"Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods","volume":"48","author":"Bulik","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.06.023_bib12","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/jac\/dky276","article-title":"Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study","volume":"73","author":"Haldorsen","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.06.023_bib13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cmi.2019.08.005","article-title":"Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli","volume":"25","author":"Antonelli","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.06.023_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14787210.2020.1760844","article-title":"Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspective","volume":"18","author":"Reyes","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2022.06.023_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cmi.2021.05.002","article-title":"Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations","volume":"28","author":"Carrara","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.06.023_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.06.023_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0035-1544208","article-title":"Carbapenemase-producing enterobacteriaceae","volume":"36","author":"Doi","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.06.023_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1469-0691.12697","article-title":"Treating infections caused by carbapenemase-producing Enterobacteriaceae","volume":"20","author":"Tzouvelekis","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.06.023_bib19","series-title":"CLSI guideline M100","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2020"},{"key":"10.1016\/j.cmi.2022.06.023_bib20","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: the phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.06.023_bib21","series-title":"Do we report carbapenem susceptibility accurately for Klebsiella pneumoniae isolates in the clinical microbiology laboratory?","author":"Ozturk","year":"2015"},{"key":"10.1016\/j.cmi.2022.06.023_bib22","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.06.023_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijantimicag.2017.08.019","article-title":"Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection","volume":"51","author":"Giannella","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2022.06.023_bib24","doi-asserted-by":"crossref","first-page":"e00794","DOI":"10.1128\/AAC.00794-17","article-title":"Population pharmacokinetics of high-dose continuous-infusion meropenem and considerations for use in the treatment of infections due to KPC-producing Klebsiella pneumoniae","volume":"61","author":"Cojutti","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.06.023_bib25","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/cid\/ciaa122","article-title":"Carbapenem-resistant Enterobacterales, carbapenem resistant organisms, carbapenemase-producing Enterobacterales, and carbapenemase-producing organisms: terminology past its \u201csell-by date\u201d in an era of new antibiotics and regional carbapenemase epidemiology","volume":"71","author":"Livermore","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.06.023_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cmi.2019.12.006","article-title":"The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases","volume":"26","author":"Kidd","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.06.023_bib27","doi-asserted-by":"crossref","first-page":"e01195","DOI":"10.1128\/AAC.01195-18","article-title":"Treatment of infections by OXA-48-producing enterobacteriaceae","volume":"62","author":"Stewart","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.06.023_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00186-21","article-title":"Enhanced carbapenem resistance through multimerization of plasmids carrying carbapenemase genes","volume":"12","author":"Abe","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.cmi.2022.06.023_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkx427","article-title":"MIC-based dose adjustment: facts and fables","volume":"73","author":"Mouton","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.06.023_bib30","doi-asserted-by":"crossref","first-page":"e02019","DOI":"10.1128\/JCM.02019-20","article-title":"Variability in zinc concentration among Mueller-Hinton broth brands: impact on antimicrobial susceptibility testing of metallo-\u03b2-lactamase-producing Enterobacteriaceae","volume":"58","author":"Bilinskaya","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.06.023_bib31","first-page":"e01760","article-title":"Effects of microplate type and broth additives on microdilution MIC susceptibility assays","volume":"63","author":"Kavanagh","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22003378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22003378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:33:48Z","timestamp":1761118428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22003378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1198743X22003378"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.06.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}